Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition
Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation.
08 July 2026
08 July 2026
Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.